March 25 (Reuters) - Somnomed Ltd SOM.AX :
* COVID 19 EXPECTED TO HAVE SIGNIFICANT BUT SHORT-TERM NEGATIVE IMPACT ON CO'S BUSINESS OF PROVIDING SOMNODENT ORAL APPLIANC
* CEO SALARY REDUCED BY 50% UNTIL FURTHER NOTICE
* DIRECTORS WILL FORGO ALL FEES UNTIL FURTHER NOTICE
* DECIDED TO REVOKE FY20 GUIDANCE AT THIS POINT IN TIME AND BELIEVES IT CANNOT PROVIDE AN UPDATED GUIDANCE DUE TO COVID 19